publication date: Dec. 26, 2010

In this issue: 

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.

First NCI Director To Resign Due To Presidential Election?

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

Firm Wins Patent For Method, Apparatus For Cryoablation.

Download (PDF 343KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.